Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Evolving Overdose Crisis Shakes Previously Effective Treatments
11/27/2023

By Taylor Sisk, KFF Health News

By Taylor Sisk, KFF Health News ...
The prevalence of synthetic drugs is undercutting a previously effective and widely embraced opioid use disorder treatment tactic. Now, the model pioneered in Vermont a decade ago and adopted at sites nationwide, especially in hard-to-reach...
The prevalence of synthetic drugs is undercutting a previously effective and widely embraced opioid use disorder treatment tactic. Now, the model pioneered in Vermont a decade ago and adopted at sites nationwide, especially in hard-to-reach...
The prevalence of synthetic...
11/27/2023
Pharmacy Learning Network
News
Crucial Research Funding: Unveiling Strategies to Combat Widespread and Deadly Addictions in the US
11/22/2023

Danielle Sposato

Danielle Sposato
Sanford Burnham Prebys researchers have secured federal grants totaling almost $25 million to propel their investigations and clinical trials aimed at understanding and treating addiction.
Sanford Burnham Prebys researchers have secured federal grants totaling almost $25 million to propel their investigations and clinical trials aimed at understanding and treating addiction.
Sanford Burnham Prebys...
11/22/2023
Pharmacy Learning Network

Advertisement

News
Analysis of Symptom Improvements in Patients With MF Receiving Momelotinib in the SIMPLIFY Studies
11/22/2023
Grace Taylor, MS, MA
Ruben A. Mesa, DO, and colleagues analyzed changes in total symptom scores and individual symptom scores of patients with myelofibrosis who participated in the SIMPLIFY-1 and SIMPLIFY-2 studies.
Ruben A. Mesa, DO, and colleagues analyzed changes in total symptom scores and individual symptom scores of patients with myelofibrosis who participated in the SIMPLIFY-1 and SIMPLIFY-2 studies.
Ruben A. Mesa, DO, and...
11/22/2023
Pharmacy Learning Network
News
Hand Sanitizer Pulled
11/22/2023
Jolynn Tumolo
The recall affects 4848 bottles of Equate hand sanitizer (ethyl alcohol 62%), 7.5 fluid ounces (221 mL; UPC 6 81131 05961 9), from lot 006511. The affected sanitizer was distributed in Puerto Rico.
The recall affects 4848 bottles of Equate hand sanitizer (ethyl alcohol 62%), 7.5 fluid ounces (221 mL; UPC 6 81131 05961 9), from lot 006511. The affected sanitizer was distributed in Puerto Rico.
The recall affects 4848 bottles...
11/22/2023
Pharmacy Learning Network
News
Potency Concerns Prompt Hand Sanitizer Recall
11/22/2023
Jolynn Tumolo
Omega & Delta Co. Inc. voluntarily initiated the recall on October 20, 2023. On November 14, 2023, the FDA designated the recall Class II, signaling use of the product could cause temporary or medically reversible adverse health consequences....
Omega & Delta Co. Inc. voluntarily initiated the recall on October 20, 2023. On November 14, 2023, the FDA designated the recall Class II, signaling use of the product could cause temporary or medically reversible adverse health consequences....
Omega & Delta Co. Inc....
11/22/2023
Pharmacy Learning Network

Advertisement

News
Medical Gas Recalled
11/22/2023
Jolynn Tumolo
Family Medical Supply Inc is recalling 26,657 cylinders of compressed oxygen because of deviations from Current Good Manufacturing Practices, according to the November 22, 2023, US Food and Drug Administration (FDA) Enforcement Report.
Family Medical Supply Inc is recalling 26,657 cylinders of compressed oxygen because of deviations from Current Good Manufacturing Practices, according to the November 22, 2023, US Food and Drug Administration (FDA) Enforcement Report.
Family Medical Supply Inc is...
11/22/2023
Pharmacy Learning Network
News
Understanding the Opioid Epidemic: Diagnosis, Risk Factors, Treatment Options, and Addiction Reduction Strategies
11/22/2023
Hannah Musick
This summary addresses the diagnosis and risk factors of opioid use disorder, as well as the ineffectiveness of opioids as long-term pain medications, the physical manifestations and effects of opioid abuse, the need for substance use...
This summary addresses the diagnosis and risk factors of opioid use disorder, as well as the ineffectiveness of opioids as long-term pain medications, the physical manifestations and effects of opioid abuse, the need for substance use...
This summary addresses the...
11/22/2023
Pharmacy Learning Network
News
Drug Purchases From Foreign Countries Lack US Safeguards
11/21/2023
Jolynn Tumolo
Pharmacists, prescribers, and other team members involved in prescription drug delivery can help patients by talking to them about drug safety “and the dangers of purchasing unregulated drugs through illegal online pharmacies,” the authors...
Pharmacists, prescribers, and other team members involved in prescription drug delivery can help patients by talking to them about drug safety “and the dangers of purchasing unregulated drugs through illegal online pharmacies,” the authors...
Pharmacists, prescribers, and...
11/21/2023
Pharmacy Learning Network

Advertisement

News
Chemical Engineers Receive $3.5 Million Grant to Investigate Adolescent Exposure and Opioid Addiction
11/20/2023
Hannah Musick
The National Institutes of Health’s National Institute on Drug Abuse is awarding a 5-year, $3.5 million grant to the Virginia Tech Department of Chemical Engineering’s pioneering research to understand how adolescent exposure may contribute...
The National Institutes of Health’s National Institute on Drug Abuse is awarding a 5-year, $3.5 million grant to the Virginia Tech Department of Chemical Engineering’s pioneering research to understand how adolescent exposure may contribute...
The National Institutes of...
11/20/2023
Pharmacy Learning Network
News
Debate Emerges Over Pfizer's Disclosure of Safety Signal in RSV Vaccine Trial
11/20/2023
Hannah Musick
An investigation by The BMJ has Pfizer facing criticism for failing to inform pregnant women participating in an RSV vaccine trial of the suspension of a similar GSK trial due to a safety concern regarding preterm birth.
An investigation by The BMJ has Pfizer facing criticism for failing to inform pregnant women participating in an RSV vaccine trial of the suspension of a similar GSK trial due to a safety concern regarding preterm birth.
An investigation by The BMJ has...
11/20/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use